These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 2772076

  • 1. [Initial experiences with the Reiber 1979 determination of autochthonous IgG production within the scope of clinical and immunologic follow-up studies in multiple sclerosis treated with immunosuppressive therapy].
    Dachsel R, Köppel C.
    Psychiatr Neurol Med Psychol (Leipz); 1989 Jul; 41(7):420-5. PubMed ID: 2772076
    [Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa, Kir'iakov VA, Sapfirova VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Jul; 90(2):119-26. PubMed ID: 2160156
    [No Abstract] [Full Text] [Related]

  • 3. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
    Gladstone DE, Zamkoff KW, Krupp L, Peyster R, Sibony P, Christodoulou C, Locher E, Coyle PK.
    Arch Neurol; 2006 Oct; 63(10):1388-93. PubMed ID: 16908728
    [Abstract] [Full Text] [Related]

  • 4. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 5. Isoprinosine in multiple sclerosis treatment: a preliminary study.
    Mazzarello P, Rocchelli B, Poloni M, Delodovici M, Pinelli P.
    Schweiz Arch Neurol Neurochir Psychiatr; 1982 May; 131(2):175-9. PubMed ID: 6187064
    [Abstract] [Full Text] [Related]

  • 6. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone.
    Staugaitis SM, Shapshak P, Myers LW, Ellison GW, Tourtellotte WW, Lee M.
    Ann Neurol; 1985 Sep; 18(3):356-7. PubMed ID: 2996418
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?
    Bar-Or A, Oger J, Gibbs E, Niino M, Aziz T, Renoux C, Alatab S, Shi FD, Campagnolo D, Jalili F, Rhodes S, Yamashita T, Fan B, Freedman MS, Panitch H, Arnold DL, Vollmer T.
    Mult Scler; 2009 Aug; 15(8):959-64. PubMed ID: 19667022
    [Abstract] [Full Text] [Related]

  • 17. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E, Zivadinov R, Krasensky J, Dwyer MG, Novakova I, Dolezal O, Ticha V, Dusek L, Houzvickova E, Cox JL, Bergsland N, Hussein S, Svobodnik A, Seidl Z, Vaneckova M, Horakova D.
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [Abstract] [Full Text] [Related]

  • 18. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
    Reinhold-Keller E.
    Dtsch Med Wochenschr; 2002 Sep 13; 127(37):1909-10. PubMed ID: 12226791
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Aspects of immunosuppressive therapy of multiple sclerosis].
    Fischer W.
    Psychiatr Neurol Med Psychol Beih; 1975 Sep 13; 20-21():23-6. PubMed ID: 829627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.